Implementing yesterday's promises

American Journal of Health-System Pharmacy

Volumn 57, Issue 6, 2000, Pages 576-581

  Helling, Dennis K ^a  

^a KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMBULATORY CARE; CONFERENCE PAPER; HEALTH CARE COST; HEALTH SERVICE; PHARMACEUTICAL CARE; PHARMACIST; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0034654649     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/57.6.576     Document Type: Conference Paper

References (19)

1. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990; 47:533-43.
2. Strand I.M, Morely PC, Cipolle R et al. Drug-related problems: their structure and function. DICP. 1990; 24:1093-7.
3. Johnson JA, Bootman JL. Drug-related morbidity and mortality: a cost-of-illness model. Arch Intern Med. 1995; 155:1949-56.
4. Bootman JL, Harrison DL, Cox E. The health care cost of drug-related morbidity and mortality in nursing facilities. Arch Intern Med 1997; 157:2089-96.
5. McKenney JM, Slining JM, Henderson HR et al. The effect of clinical pharmacy services on patients with essential hypertension. Circulation. 1973; 48:1104-11.
6. Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care. Arch Intern Med. 1998; 158:1641-7.
7. Bond CA, Raehl CL, Franke T. Clinical pharmacy services and hospital mortality rates. Pharmacotherapy. 1999; 19:556-64.
8. Bond CA, Raehl CL, Pitterle ME et al. Health care professional staffing, hospital characteristics, and hospital mortality rates. Pharmacotherapy. 1999; 19:130-8.
9. Leape LL, Cullen DJ, Clapp MD et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999; 282:267-70.
10. Gattis WA, Hasselblad V, Whellan DJ et al. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team. Arch Intern Med. 1999; 159:1939-45.
11. Carter BL, Helling DK. Ambulatory care pharmacy services: Has the agenda changed? Ann Pharmacother. In press.
12. Christensen DB, Holmes G, Fassett WE et al. Influence of a financial incentive on cognitive services: CARE project design/implementation. J Am Pharm Assoc. 1999; 39:629-39.
13. Christensen DB, Hansen RW. Characteristics of pharmacies and pharmacists associated with the provision of cognitive services in the community setting. J Am Pharm Assoc. 1999; 39:640-9.
14. Smith DH, Fassett WE, Christensen DB. Washington State CARE project: downstream cost changes associated with the provision of cognitive services by pharmacists. J Am Pharm Assoc. 1999; 39:650-7.
15. Kradjan WA, Schulz R, Christensen DB et al. Patients' perceived benefit from and satisfaction with asthma-related pharmacy services. J Am Pharm Assoc. 1999; 39:658-66.
16. Grasha AF. Into the abyss: seven principles for identifying the causes of and preventing human error in complex systems. Am J Health-Syst Pharm. 2000; 57:554-64.
17. Pierpaoli PG. An iconoclastic perspective on progress in pharmacy practice. Am J Health-Syst Pharm. 1995; 52:1763-70.
18. Gouveia WA. At center stage: pharmacy in the next century. Am J Health-Syst Pharm. 1999; 56:1613-8.
19. English T. Gans reflects on a decade of pharmacy's accomplishments. Pharm Today. 1999; 5(9):1,26.